Radient Pharmaceuticals Corporation · Tustin, CA United States ·(NYSE Alternext: RPC)

Radient Pharmaceuticals (formerly AMDL) is ready to hunt down cancer and sell face cream. The company has developed an in vitro blood test to detect over a dozen forms of cancer. Marketed as Onko-Sure, the test is approved for use in Europe and Asia; in the US it is approved for monitoring colorectal cancer. Radient has also developed Elleuxe, a high-dollar skin cream it plans to sell through spas and retailers. However, in the meantime, the company makes most of its money through its largest subsidiary, Jade Pharmaceuticals. Jade manufactures and distributes nutritional supplements, generic drugs, and over-the-counter pharmaceuticals in China. To read the full description, subscribe now.